A Phase 2 interventional study of Picolight + Coolprep and Picolight + Clicolon in Healthy, sponsored by National Cancer Center, Korea. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-26.
Sponsored by National Cancer Center, Korea · Phase 2, Interventional, and Screening
The purpose of this study to bowel cleansing evaluation of mixed two other type bowel preparation drug(PICOLIGHT plus COOLPREP, PICOLIGHT plus CLICOLON).
To evaluate mixed-drug bowel preparation methods for decreasing side effect and increasing compliance
Picolight + Coolprep [Day-Prior] Picolight + Clicolon [Day-Prior] Picolight + Coolprep [Split-Dose] Picolight + Clicolon [Split-Dose]
National Cancer Center, Korea is the lead sponsor of 193 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)\[Day-Prior\]
Drug: Picolight + Coolprep
Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) \[Day-Prior\]
Drug: Picolight + Clicolon
Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)\[Split-Dose\]
Drug: Picolight + Coolprep
Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)\[Split-Dose\]
Drug: Picolight + Clicolon
Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)\[Day-Prior\] Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)\[Split-Dose\]
Also known as: Picolight(Citric acid, Magnesium Oxide, Sodium picosulfate), Coolprep(PEG 3350 + EL, Ascobic acid, Sodium sulfate)
Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) \[Day-Prior\] Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)\[Split-Dose\]
Also known as: Picolight(Citric acid, Magnesium Oxide, Sodium picosulfate), Clicolon(Sodium phosphate)
Bowel preparation quality
Aronchick bowel preparation score; Excellent: small volume of clear liquid or greater than 95% of surface seen Good: large volume of clear liquid 5% to 25% of the surface but greater than 90% of surface seen Fair: some semi-solid stool that could be suctioned or washed away, but greater than 90% of surface seen Poor: semi-solid stool that could not be suctioned or washed away and less than 90% of surface seen Inadequate: re-preparation needed (\* 'success' of bowel preparation is defined as Aronchick's 'Excellent' or 'Good'.)
Time frame: the day of colonoscopy
Patient tolerance
Patient's tolerance; 1= "none"; 2= "mild"; 3= "bothersome"; 4= "distressing"; 5= "severely distressing"
Time frame: the day of colonoscopy
Adenoma detection rate
Adenoma detection rate (%)
Time frame: The day of colonoscopy
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Center, Korea